Computer model simulates cancer growth and treatment at nano scale

by Robyn Mills

(Medical Xpress)—A University of Adelaide PhD student has developed a computer model for simulating cancer tumour growth and treatment which is attracting interest from around the world as a first-line assessment of potential treatments.

The first of its kind in the world, the model simulates the growth of tumour from single cells and the effect of cancer treatments such as radiation at the nanoscale level.

"Unlike other cancer models, this model simulates the and effects of various treatments, right through to the probability of survival of cells and whether they have been destroyed by the treatment," says Michael Douglass, PhD student in the University's School of Chemistry and Physics.

The research, supervised by Associate Professor Eva Bezak, School of Chemistry and Physics and Chief Physicist, Royal Adelaide Hospital (RAH) and Dr Scott Penfold, Medical Physics Co-ordinator in the School, is currently focussed on radiotherapy.

"We model individual radiation particle interactions on scales smaller than the size of a water molecule," says Mr Douglass, who is also a medical physicist in the Department of Medical Physics at the RAH. We simulate the resultant biological damage to each cell in the tumour and how the cell repairs its DNA after being exposed to radiation."

The model is now being used to study new techniques such as the use of gold-nanoparticles to reduce the radiation dose needed to destroy tumours, and so reduce or eliminate acute radiation side-effects.

"Targeting and destroying an individual cancer cell in the human body is a bit like spotting a fly from several kilometres away," says Mr Douglass. "Since we can't see it, the only way to ensure the fly has been killed is to use a highly destructive nuclear weapon which results in huge collateral damage. When the fly starts to reproduce and becomes a huge swarm, then we can see it and take more precise action, but by that time the condition has become quite serious in terms of tumour growth and spread of the cancer."

"The beauty of this model is that we can investigate the actions of new treatments such as gold nano-particle therapy to see what happens when we can't look at it experimentally. The processes are happening on such a small scale that computer modelling is the only way of understanding how they are working.

"We can use the model to investigate what will happen with any therapy so we can verify it as a potential treatment and then, if it's looking promising, go ahead with clinical trials."

Over the next year, the model will be further developed in many international collaborations including Loma Linda University Medical Centre in the United States to study the effects of proton radiotherapy. It has also attracted the interest of NASA to study the effects of cosmic radiation on astronauts.

The model's algorithms also will be released to researchers around the world this year.

add to favorites email to friend print save as pdf

Related Stories

Oxygen levels in tumours affect response to treatment

Nov 07, 2013

(Medical Xpress)—The genetic make-up of a patient's tumour could be used to personalise their treatment, and help to decide whether they would benefit from receiving additional drugs as part of their radiotherapy programme, ...

World first trial to improve prostate cancer care

Nov 28, 2013

Researchers and clinicians from the University of Sydney and the Northern Sydney Cancer Centre are leading a world first clinical trial using a tracking system to improve prostate cancer radiotherapy treatment.

Recommended for you

Discovery could lead to new cancer treatment

Aug 29, 2014

A team of scientists from the University of Colorado School of Medicine has reported the breakthrough discovery of a process to expand production of stem cells used to treat cancer patients. These findings could have implications ...

Is the HPV vaccine necessary?

Aug 29, 2014

As the school year starts in full swing many parents wonder if their child should receive the HPV vaccine, which is recommended for girls ages 11-26 and boys 11-21. There are a lot of questions and controversy around this ...

User comments